$3.12
-0.18-5.45%
In chiusura: -
$3.14
0.020.64%
After hour: 5:27 PM EDT
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su Esperion Therapeutics Inc (NASDAQ:ESPR) è aumentato durante l'ultimo periodo di rilevazione, aumentando da 22.35M a 24.80M. Questo rappresenta il 12.36% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Esperion Therapeutics Corp (XNAS:ESPR) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 7.42M azioni scambiate al giorno, ci vorrebbero 3.34 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
24.80M
Vendite allo scoperto %
12.4%
Giorni di copertura
3.34
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
ESPR | Esperion Therapeutics, Inc. Co | 09/15/2025 | 09/24/2025 | 12.36% | 200,740,241 | 24,801,814 | 7,423,790 | 3.34 | |
ESPR | Esperion Therapeutics, Inc. Co | 08/29/2025 | 09/10/2025 | 11.13% | 200,740,241 | 22,348,965 | 4,648,073 | 4.81 | |
ESPR | Esperion Therapeutics, Inc. Co | 08/15/2025 | 08/26/2025 | 11.28% | 200,740,241 | 22,636,104 | 5,817,737 | 3.89 | |
ESPR | Esperion Therapeutics, Inc. Co | 07/31/2025 | 08/11/2025 | 11.72% | 197,316,878 | 23,127,867 | 6,469,551 | 3.57 | |
ESPR | Esperion Therapeutics, Inc. Co | 07/15/2025 | 07/24/2025 | 11.20% | 197,316,878 | 22,097,452 | 3,163,582 | 6.98 | |
ESPR | Esperion Therapeutics, Inc. Co | 06/30/2025 | 07/10/2025 | 12.18% | 197,316,878 | 24,026,028 | 2,905,516 | 8.27 | |
ESPR | Esperion Therapeutics, Inc. Co | 06/13/2025 | 06/25/2025 | 12.22% | 197,316,878 | 24,113,664 | 4,034,608 | 5.98 | |
ESPR | Esperion Therapeutics, Inc. Co | 05/30/2025 | 06/10/2025 | 13.35% | 197,316,878 | 26,342,829 | 4,787,929 | 5.5 | |
ESPR | Esperion Therapeutics, Inc. Co | 05/15/2025 | 05/27/2025 | 14.16% | 197,316,878 | 27,945,316 | 7,206,278 | 3.88 | |
ESPR | Esperion Therapeutics, Inc. Co | 04/30/2025 | 05/09/2025 | 15.14% | 197,266,837 | 29,864,966 | 4,548,542 | 6.57 | |
ESPR | Esperion Therapeutics, Inc. Co | 04/15/2025 | 04/25/2025 | 15.22% | 197,266,837 | 30,028,700 | 6,835,234 | 4.39 | |
ESPR | Esperion Therapeutics, Inc. Co | 03/31/2025 | 04/09/2025 | 14.20% | 197,333,394 | 28,023,201 | 3,819,449 | 7.34 | |
ESPR | Esperion Therapeutics, Inc. Co | 03/14/2025 | 03/25/2025 | 14.65% | 197,333,394 | 28,900,005 | 5,417,684 | 5.33 | |
ESPR | Esperion Therapeutics, Inc. Co | 02/28/2025 | 03/11/2025 | 14.77% | 197,333,394 | 29,144,177 | 2,535,682 | 11.49 | |
ESPR | Esperion Therapeutics, Inc. Co | 02/14/2025 | 02/26/2025 | 14.30% | 196,519,679 | 28,100,794 | 2,862,906 | 9.82 | |
ESPR | Esperion Therapeutics, Inc. Co | 01/31/2025 | 02/11/2025 | 15.90% | 196,519,679 | 31,243,405 | 5,473,874 | 5.71 | |
ESPR | Esperion Therapeutics, Inc. Co | 01/15/2025 | 01/27/2025 | 17.29% | 196,519,679 | 33,978,548 | 4,865,289 | 6.98 | |
ESPR | Esperion Therapeutics, Inc. Co | 12/31/2024 | 01/10/2025 | 16.46% | 196,519,679 | 32,346,325 | 4,494,351 | 7.2 | |
ESPR | Esperion Therapeutics, Inc. Co | 12/13/2024 | 12/24/2024 | 12.96% | 196,519,679 | 25,474,270 | 12,243,603 | 2.08 | |
ESPR | Esperion Therapeutics, Inc. Co | 11/29/2024 | 12/10/2024 | 15.52% | 196,519,679 | 30,492,669 | 4,843,168 | 6.3 | |
ESPR | Esperion Therapeutics, Inc. Co | 11/15/2024 | 11/26/2024 | 15.90% | 196,519,679 | 31,247,976 | 6,432,551 | 4.86 | |
ESPR | Esperion Therapeutics, Inc. Co | 10/31/2024 | 11/11/2024 | 17.10% | 195,709,203 | 33,463,960 | 2,818,688 | 11.87 | |
ESPR | Esperion Therapeutics, Inc. Co | 10/15/2024 | 10/24/2024 | 18.08% | 195,709,203 | 35,388,048 | 3,626,774 | 9.76 | |
ESPR | Esperion Therapeutics, Inc. Co | 09/30/2024 | 10/09/2024 | 19.14% | 195,709,203 | 37,467,113 | 2,938,306 | 12.75 | |
ESPR | Esperion Therapeutics, Inc. Co | 09/13/2024 | 09/24/2024 | 19.46% | 195,709,203 | 38,090,309 | 2,852,040 | 13.36 | |
ESPR | Esperion Therapeutics, Inc. Co | 08/30/2024 | 09/11/2024 | 20.66% | 195,709,203 | 40,438,871 | 3,425,676 | 11.8 | |
ESPR | Esperion Therapeutics, Inc. Co | 08/15/2024 | 08/26/2024 | 21.32% | 195,709,203 | 41,734,471 | 5,430,158 | 7.69 | |
ESPR | Esperion Therapeutics, Inc. Co | 07/31/2024 | 08/09/2024 | 20.18% | 188,944,801 | 38,135,175 | 4,520,974 | 8.44 | |
ESPR | Esperion Therapeutics, Inc. Co | 07/15/2024 | 07/24/2024 | 20.86% | 188,944,801 | 39,417,019 | 7,179,081 | 5.49 | |
ESPR | Esperion Therapeutics, Inc. Co | 06/28/2024 | 07/10/2024 | 12.46% | 188,944,801 | 23,549,800 | 12,839,730 | 1.83 | |
ESPR | Esperion Therapeutics, Inc. Co | 06/14/2024 | 06/26/2024 | 13.17% | 188,944,801 | 24,887,802 | 8,669,381 | 2.87 | |
ESPR | Esperion Therapeutics, Inc. Co | 05/31/2024 | 06/11/2024 | 11.58% | 188,944,801 | 21,888,556 | 6,714,987 | 3.26 | |
ESPR | Esperion Therapeutics, Inc. Co | 05/15/2024 | 05/24/2024 | 13.18% | 188,944,801 | 24,911,275 | 9,998,005 | 2.49 | |
ESPR | Esperion Therapeutics, Inc. Co | 04/30/2024 | 05/09/2024 | 10.51% | 188,944,801 | 19,867,208 | 4,876,339 | 4.07 | |
ESPR | Esperion Therapeutics, Inc. Co | 04/15/2024 | 04/24/2024 | 9.85% | 188,885,075 | 18,601,646 | 9,220,773 | 2.02 | |
ESPR | Esperion Therapeutics, Inc. Co | 03/28/2024 | 04/09/2024 | 12.02% | 165,705,544 | 19,922,282 | 9,624,787 | 2.07 | |
ESPR | Esperion Therapeutics, Inc. Co | 03/15/2024 | 03/26/2024 | 10.66% | 165,705,544 | 17,665,969 | 3,817,014 | 4.63 | |
ESPR | Esperion Therapeutics, Inc. Co | 02/29/2024 | 03/11/2024 | 10.23% | 165,705,544 | 16,951,095 | 4,996,540 | 3.39 | |
ESPR | Esperion Therapeutics, Inc. Co | 02/15/2024 | 02/27/2024 | 11.64% | 159,575,624 | 18,569,333 | 4,371,702 | 4.25 | |
ESPR | Esperion Therapeutics, Inc. Co | 01/31/2024 | 02/09/2024 | 12.58% | 159,575,624 | 20,068,482 | 7,905,620 | 2.54 | |
ESPR | Esperion Therapeutics, Inc. Co | 01/12/2024 | 01/24/2024 | 12.66% | 159,575,624 | 20,198,605 | 7,632,023 | 2.65 | |
ESPR | Esperion Therapeutics, Inc. Co | 12/29/2023 | 01/10/2024 | 21.11% | 94,370,624 | 19,923,516 | 7,041,618 | 2.83 | |
ESPR | Esperion Therapeutics, Inc. Co | 12/15/2023 | 12/27/2023 | 19.33% | 94,370,624 | 18,241,412 | 5,897,180 | 3.09 | |
ESPR | Esperion Therapeutics, Inc. Co | 11/30/2023 | 12/11/2023 | 18.80% | 94,370,624 | 17,739,980 | 3,211,529 | 5.52 | |
ESPR | Esperion Therapeutics, Inc. Co | 11/15/2023 | 11/27/2023 | 19.40% | 94,370,624 | 18,306,254 | 3,247,325 | 5.64 | |
ESPR | Esperion Therapeutics, Inc. Co | 10/31/2023 | 11/09/2023 | 19.31% | 94,370,624 | 18,218,864 | 3,466,162 | 5.26 | |
ESPR | Esperion Therapeutics, Inc. Co | 10/13/2023 | 10/24/2023 | 21.93% | 87,647,108 | 19,218,978 | 3,715,987 | 5.17 | |
ESPR | Esperion Therapeutics, Inc. Co | 09/29/2023 | 10/10/2023 | 22.61% | 87,647,108 | 19,813,551 | 5,841,976 | 3.39 |
In cerca di azioni più vendute allo scoperto?